Validation and Reliability of the CHO-KLAT in Turkish
1 other identifier
interventional
100
1 country
4
Brief Summary
The aim of this study is to investigate the Turkish validity and reliability of the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool version2.0. Patients aged 4-18 years with hemophilia a or b will be included in the study. The study was planned as a multicenter and it is aimed to reach 100 patients. The process included four steps: a linguistic adaptation, cognitive debriefing interviews with children and their parents, a validity assessment with the Pediatric Quality of Life Inventory (PedsQL) as a comparator, and a test retest reliability assessment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2022
Shorter than P25 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2022
CompletedFirst Submitted
Initial submission to the registry
June 27, 2022
CompletedFirst Posted
Study publicly available on registry
June 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedJune 30, 2022
June 1, 2022
3 months
June 27, 2022
June 29, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
HRQoL questionnaire
Health related quality of life
1-2 week
Study Arms (1)
Hemophilia
OTHEREvaluation of quality of life of children with hemophilia in Turkey
Interventions
Evaluation of health related quality of life of boys with hemophilia with the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool and the Pediatric Inventory of Quality of Life
Eligibility Criteria
You may qualify if:
- have Hemophilia A or B
You may not qualify if:
- Did not have significant cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yuzuncu Yil Universitylead
- Hasan Kalyoncu Universitycollaborator
- University of Gaziantepcollaborator
- Acıbadem Adana Hospitalcollaborator
Study Sites (4)
Adana Acibadem Hospital
Adana, Turkey (Türkiye)
Gaziantep University
Gaziantep, Turkey (Türkiye)
Hasan Kalyoncu University
Gaziantep, Turkey (Türkiye)
Van Yuzuncu Yıl University
Van, 65100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ayse Merve Tat, Asst.Prof
Van Yuzuncu Yıl University Faculty of Health Sciences
- PRINCIPAL INVESTIGATOR
Tugba Badat Gonen, PhD
Hasan Kalyoncu University Faculty Of Health Sciences
- STUDY CHAIR
Ahmet Fayik Oner, Prof MD
Van Yuzuncu Yıl University Faculty of Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 27, 2022
First Posted
June 30, 2022
Study Start
June 1, 2022
Primary Completion
September 1, 2022
Study Completion
December 1, 2022
Last Updated
June 30, 2022
Record last verified: 2022-06